Bextra Lawsuit |
|
Information on the Legal Rights of Canadians Injured by Bextra |
|
|
In September 2004, Merck announced it would be withdrawing Vioxx worldwide after a company study discovered a link between Vioxx and serious cardiovascular problems, including heart attacks and strokes. A number of other clinical trials and research studies also had established a link. Medical researchers immediately were suspicious that other pharmaceuticals in the same family of drugs also exhibited the same problems. In November 2004, a study reported in the New York Times found that Bextra users were three times more likely to suffer a heart attack or stroke than those people taking a placebo. As the evidence continued to mount, it became clear that health agencies worldwide would be forced to respond to the risk presented by Bextra. On April 7, 2005, Health Canada and the FDA forced Pfizer to issue a Bextra recall. The agencies were concerned that any benefits of the drug were outweighed by the serious health consequences. Not only was Bextra associated with cardiovascular problems, but it previously has been linked to a serious—and even fatal—skin condition known as Stevens-Johnson Syndrome. Our law firm is representing people injured by Bextra. We encourage you to contact us for more information about your legal rights to file a Bextra lawsuit. For free answers to your questions about filing a Bextra lawsuit, please complete our online contact form. |
Cox-2 Inhibitor Lawsuits |
||||||
| Greg Monforton and Partners represents Canadians injured by Cox-2 inhibitors. Studies have linked both Vioxx and Celebrex with elevated risk of heart attack and stroke. | ||||||
Contact Us |
||||||
Bextra News |
||||||
|